ClinConnect ClinConnect Logo
Search / Trial NCT04809064

Open Versus Arthroscopic Stabilization of Shoulder Instability with Subcritical Bone Loss: the OASIS Trial

Launched by UNIVERSITY OF PITTSBURGH · Mar 17, 2021

Trial Information

Current as of July 01, 2025

Recruiting

Keywords

Anterior Shoulder Instability Glenoid Bone Loss Stabilization Surgery Return To Duty Or Sport Rehabilitation

ClinConnect Summary

The OASIS Trial is studying different surgical methods to treat shoulder instability, particularly for people who have experienced a traumatic shoulder dislocation and have some bone loss in their shoulder joint. The goal is to find out which surgery helps patients recover the fastest so they can return to their jobs, sports, or military duties, while also improving their shoulder function. This trial is open to military personnel and civilians aged 17 to 50 who have had a recent shoulder dislocation and have a specific amount of bone loss that can be measured through a CT scan.

Participants in the trial will undergo one of three surgical procedures and will follow a post-operative rehabilitation program. To be eligible, individuals must have experienced a recent shoulder dislocation with 10-20% bone loss in the shoulder joint but should not have any other chronic shoulder issues, significant prior injuries, or conditions that might affect their recovery. Those who join the trial can expect close monitoring and support as they work towards regaining full function in their shoulder.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Civilians and military personnel ages 17 to 50
  • Traumatic anterior shoulder dislocation
  • Associated subcritical bone loss between 10-20% less the glenoid width quantified by standard of care CT scan
  • Exclusion Criteria:
  • Chronic, non-traumatic multi-directional instability based on clinical exam.
  • Concurrent shoulder injury (e.g. rotator cuff tears, motor nerve pathologies, osteoarthritis of a Samilson-Prieto grade \>2).
  • Prior instability or rotator cuff procedure on involved shoulder (including intra-articular soft tissue surgery).
  • Humeral sided bone lesion (Hill-Sachs lesion) that is sufficiently large enough to render the lesion "off-track" even after a bony augmentation procedure would be performed.
  • Neuromuscular and other movement control pathologies including seizures.
  • Vascular injury associated with the shoulder trauma.
  • Traumatic brain injury or any condition that would preclude the ability to comply with post-operative guidelines.
  • Does not plan to return to pre-injury levels of work, sports or military duty.

About University Of Pittsburgh

The University of Pittsburgh is a leading research institution known for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a robust infrastructure for research and a multidisciplinary approach, the university fosters collaboration among experts in various fields, facilitating the development of novel therapies and interventions. Its clinical trial programs emphasize ethical standards, patient safety, and the integration of cutting-edge technology, making the University of Pittsburgh a pivotal contributor to the landscape of clinical research and a trusted partner in the pursuit of health advancements.

Locations

Winston Salem, North Carolina, United States

Pittsburgh, Pennsylvania, United States

Farmington, Connecticut, United States

Durham, North Carolina, United States

Chapel Hill, North Carolina, United States

San Diego, California, United States

Chapel Hill, North Carolina, United States

Fort Sam Houston, Texas, United States

Fort Carson, Colorado, United States

Charlottesville, Virginia, United States

Nashville, Tennessee, United States

Camp Lejeune, North Carolina, United States

Bethesda, Maryland, United States

Vail, Colorado, United States

Annapolis, Maryland, United States

Providence, Rhode Island, United States

Tempe, Arizona, United States

Columbus, Ohio, United States

Providence, Rhode Island, United States

Patients applied

0 patients applied

Trial Officials

Adam Popchak, PhD, PT

Principal Investigator

University of Pittsburgh

Jonathan Dickens, MD

Principal Investigator

Duke University

James J Irrgang, PhD, PT, ATC

Study Chair

University of Pittsburgh

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials